BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11524396)

  • 1. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.
    Friedman PA; Dijkman B; Warman EN; Xia HA; Mehra R; Stanton MS; Hammill SC
    Circulation; 2001 Aug; 104(9):1023-8. PubMed ID: 11524396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias.
    Friedman PA; Ip JH; Jazayeri M; Lobban JH; Olshansky B; Zhou D; Knowles T; Euler DE;
    J Interv Card Electrophysiol; 2004 Apr; 10(2):103-10. PubMed ID: 15014210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.
    Euler DE; Friedman PA
    Card Electrophysiol Rev; 2003 Dec; 7(4):355-8. PubMed ID: 15071253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
    Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with implantable atrial and combined atrioventricular defibrillators.
    Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Schimpf R; Vahlhaus C; Welz A; Lüderitz B
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():185-95. PubMed ID: 10590507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance.
    Schuchert A; Boriani G; Wollmann C; Biffi M; Kühl M; Sperzel J; Stiller S; Gasparini G; Böcker D
    J Interv Card Electrophysiol; 2005 Mar; 12(2):149-56. PubMed ID: 15744468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1196-205. PubMed ID: 11083239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
    Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator.
    Ricci R; Pignalberi C; Santini M
    Card Electrophysiol Rev; 2003 Dec; 7(4):348-51. PubMed ID: 15071251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):309-18. PubMed ID: 11500586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.